IN8bio Names Kate Rochlin, PhD Assistant Vice President Operations and Innovation

NEW YORK, Sept. 17, 2020 (GLOBE NEWSWIRE) -- IN8bio, Inc., a clinical-stage biotechnology company focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells, today announced that Kate Rochlin, PhD has been named Assistant Vice President for Operations and Innovation. Dr